Loading organizations...
Key people at Atherton.
Atherton was founded in 1889 by Bill Paseman (Co-founder, VP R&D).
Atherton is a Melbourne, Victoria, Australia-based manufacturer and supplier of sterilization equipment and infection control products for the healthcare and scientific sectors. The company designs, builds, and services comprehensive capital equipment solutions, including washer disinfectors and boiling water sterilizers, to process reusable medical and scientific instruments. Operating through a B2B model, the enterprise provides direct sales, parts, and ongoing aftermarket maintenance to hospitals, medical facilities, scientific research laboratories, and pharmaceutical companies. Originally established as a plumbing firm before expanding into mechanical services like heating, ventilation, and hot water systems in the early 1900s, the business has accumulated over 135 years of operational history. While specific financial metrics, valuation, and employee counts remain undisclosed, the organization celebrated its 130th anniversary of continuous operation in 2019. Atherton was originally founded in 1889 by Alfred Ernest Atherton.
Key people at Atherton.
Atherton was founded in 1889 by Bill Paseman (Co-founder, VP R&D).
Atherton Venture Partners is a California-based venture capital and private equity firm that invests in healthcare, life sciences, and information technology companies.[1][2] Its mission centers on backing innovative companies in these sectors, with a current portfolio emphasizing high-growth opportunities in tech-driven healthcare and IT.[1] The firm's investment philosophy focuses on early- to growth-stage ventures, leveraging its private equity expertise to support scalable businesses, contributing to the startup ecosystem by providing capital and strategic guidance to transformative companies in critical industries.[2]
Founded in the late 20th century as a prominent Silicon Valley player (exact year not specified in available data), Atherton Venture Partners emerged during the tech boom, evolving from a focus on broad tech investments to a sharpened emphasis on healthcare, life sciences, and information technology.[1][2] Key partners have built a reputation through decades of deal-making in California's innovation hub, adapting to market shifts like the rise of biotech and digital health, with pivotal moments including high-profile exits that solidified its track record.[2]
Atherton Venture Partners rides the convergence of AI-driven healthcare, biotech breakthroughs, and enterprise IT modernization, trends accelerated by post-pandemic digital transformation and aging populations demanding innovative solutions.[1] Timing is ideal amid surging investments in life sciences (projected to grow amid regulatory tailwinds) and IT resilience plays, with market forces like talent concentration in California favoring its location.[2] The firm influences the ecosystem by funding companies that bridge tech and medicine, fostering startups that address global challenges like personalized medicine and data-secure health tech.
Atherton is poised to capitalize on AI-healthcare integration and sustainable biotech, with trends like precision medicine and cybersecurity in IT shaping its next investments. Expect expanded focus on Series B/C rounds as portfolio companies scale amid economic recovery. Its influence will evolve by mentoring the next wave of unicorns, reinforcing its role as a steady force in venture—much like its foundational bet on California's enduring innovation engine.[1][2]
